Market Cap 3.86B
Revenue (ttm) 1.04M
Net Income (ttm) -298.41M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -28,693.27%
Debt to Equity Ratio 0.00
Volume 1,543,900
Avg Vol 1,559,540
Day's Range N/A - N/A
Shares Out 94.18M
Stochastic %K 18%
Beta 0.33
Analysts Strong Sell
Price Target $79.19

Company Profile

Crinetics Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. The company's lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist, which is in a Phase 3 clinical trial for the treatment of acromegaly and carcinoid syndrome associated with neuroendocrine tumors. It is also developing Atumelnant,...

Industry: Biotechnology
Sector: Healthcare
Phone: 858 450 6464
Address:
6055 Lusk Boulevard, San Diego, United States
heyupikachu1821
heyupikachu1821 Oct. 24 at 4:18 PM
$CRNX nice movement. if we can break through $46, it’s smooth sailing above
0 · Reply
jreddyN
jreddyN Oct. 24 at 2:06 AM
$CRNX Key highlights include a preliminary, investigator-assessed one-year progression-free survival (PFS) rate of 74% from an open-label Phase 2 study of paltusotine for carcinoid syndrome and poster details on the randomized Phase 3 CAREFNDR study of paltusotine and the first-in-human study of nonpeptide drug conjugate CRN09682
0 · Reply
Hanaleimike
Hanaleimike Oct. 23 at 8:51 PM
$CRNX did something happen?
0 · Reply
RayaK16
RayaK16 Oct. 23 at 6:08 PM
$CRNX Looking to get in here but why has this faltered since approval last month, anyone know? Was at $45 and i was expecting it to be over $50 by now.
3 · Reply
Supplement
Supplement Oct. 23 at 3:46 PM
$CRNX I don't understand why the Sentiment and Message Volume is so Bearish around here? Why?
0 · Reply
Hanaleimike
Hanaleimike Oct. 22 at 6:51 PM
$CRNX any news?
1 · Reply
Supplement
Supplement Oct. 21 at 3:29 PM
$CRNX dead around here... up again today!
1 · Reply
Supplement
Supplement Oct. 20 at 4:49 PM
$CRNX We're running!
0 · Reply
CH_Expat
CH_Expat Oct. 17 at 5:51 PM
$CRNX $SNDX Only two serious re-entry candidates for the moment. Would prefer them both lower though.
1 · Reply
Supplement
Supplement Oct. 15 at 12:37 PM
$CRNX Almost a 2 dollar pop in premarket. Today's going to be a good day.
1 · Reply
Latest News on CRNX
Crinetics Pharmaceuticals, Inc. - Special Call

Sep 26, 2025, 1:57 AM EDT - 4 weeks ago

Crinetics Pharmaceuticals, Inc. - Special Call


Crinetics Pharmaceuticals to Host R&D Day on June 26, 2025

Jun 16, 2025, 8:00 AM EDT - 4 months ago

Crinetics Pharmaceuticals to Host R&D Day on June 26, 2025


heyupikachu1821
heyupikachu1821 Oct. 24 at 4:18 PM
$CRNX nice movement. if we can break through $46, it’s smooth sailing above
0 · Reply
jreddyN
jreddyN Oct. 24 at 2:06 AM
$CRNX Key highlights include a preliminary, investigator-assessed one-year progression-free survival (PFS) rate of 74% from an open-label Phase 2 study of paltusotine for carcinoid syndrome and poster details on the randomized Phase 3 CAREFNDR study of paltusotine and the first-in-human study of nonpeptide drug conjugate CRN09682
0 · Reply
Hanaleimike
Hanaleimike Oct. 23 at 8:51 PM
$CRNX did something happen?
0 · Reply
RayaK16
RayaK16 Oct. 23 at 6:08 PM
$CRNX Looking to get in here but why has this faltered since approval last month, anyone know? Was at $45 and i was expecting it to be over $50 by now.
3 · Reply
Supplement
Supplement Oct. 23 at 3:46 PM
$CRNX I don't understand why the Sentiment and Message Volume is so Bearish around here? Why?
0 · Reply
Hanaleimike
Hanaleimike Oct. 22 at 6:51 PM
$CRNX any news?
1 · Reply
Supplement
Supplement Oct. 21 at 3:29 PM
$CRNX dead around here... up again today!
1 · Reply
Supplement
Supplement Oct. 20 at 4:49 PM
$CRNX We're running!
0 · Reply
CH_Expat
CH_Expat Oct. 17 at 5:51 PM
$CRNX $SNDX Only two serious re-entry candidates for the moment. Would prefer them both lower though.
1 · Reply
Supplement
Supplement Oct. 15 at 12:37 PM
$CRNX Almost a 2 dollar pop in premarket. Today's going to be a good day.
1 · Reply
Supplement
Supplement Oct. 14 at 3:55 PM
0 · Reply
Hanaleimike
Hanaleimike Oct. 13 at 7:01 PM
$CRNX what is that dip about?
1 · Reply
Supplement
Supplement Oct. 13 at 2:12 PM
0 · Reply
biostock
biostock Oct. 10 at 7:05 PM
$CRNX 35 coming.
2 · Reply
Say_Wen
Say_Wen Oct. 10 at 12:14 AM
$CRNX Be a lot cooler if this went to $55 next week.
2 · Reply
_CircuitBreaker
_CircuitBreaker Oct. 9 at 11:14 PM
Keep a close watch on CMCT! $FLUX $CRNX $GSK $BNBX ..
0 · Reply
Supplement
Supplement Oct. 9 at 1:16 PM
$CRNX Should be another leg up day, hopefully we can break $50 today. Green Green Green.
0 · Reply
Supplement
Supplement Oct. 8 at 5:32 PM
$CRNX Why so quiet around here?
3 · Reply
Supplement
Supplement Oct. 8 at 4:47 PM
$CRNX nice nice
0 · Reply
Quantumup
Quantumup Oct. 8 at 2:20 PM
Piper Sandler reiterated $CRNX Overweight-$97 and said we are buyers and continue to be bullish on PALSONIFY's launch opportunity/trajectory. $NVS $AZN Piper Sandler additionally said: CRNX has been up ~20% over the last month after PALSONIFY approval in acromegaly with a clean/broad label and thoughtful pricing. In our deep dive, we review channel checks and believe expectations heading into launch are fair with a lucrative US acromegaly TAM of~36K (~11.5K initial addressable market). Importantly, prior KOLs see a significant utility for PALSONIFY and would expect it to be eventually used in >~70% of patients. Further, we detail Street likely does not realize CRNX's comprehensive commercial infrastructure with CrinetiCARE, simple start form paperwork, and active advocacy support. Hence, we are buyers and continue to be bullish on PALSONIFY's launch opportunity/trajectory.
0 · Reply
Supplement
Supplement Oct. 8 at 1:45 PM
0 · Reply
BigDollarGains
BigDollarGains Oct. 7 at 8:31 PM
$CRNX Wow. 4 M shares trades AH. News tomorrow may be.
0 · Reply